A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.
Identifieur interne : 000B94 ( Main/Exploration ); précédent : 000B93; suivant : 000B95A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.
Auteurs : Xianfeng Lin ; Houguang Shi ; Weixing Zhang ; Zongxing Qiu ; Zheng Zhou ; Fabian Dey ; Sheng Zhong ; Hongxia Qiu ; Jianxun Xie ; Xue Zhou ; Guang Yang ; Guozhi Tang ; Hong C. Shen ; Wei ZhuSource :
- Journal of medicinal chemistry [ 1520-4804 ] ; 2019.
Abstract
Described herein is a new approach to mitigate CYP3A4 induction. In this unconventional approach, a fine-tuning of the dihedral angle between the C4 phenyl and the dihydropyrimidine core of the heteroaryldihydropyrimidine (HAP) class of capsid inhibitors successfully altered the structure-activity-relationships (SARs) of the unwanted CYP3A4 induction and the desired HBV capsid inhibition to more favorable values. This eventually led to the discovery of a new capsid inhibitor with significantly reduced CYP3A4 induction, excellent anti-HBV activity, favorable preclinical PK/PD profiles, and no early safety flags.
DOI: 10.1021/acs.jmedchem.9b01421
PubMed: 31689116
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000862
- to stream PubMed, to step Curation: 000862
- to stream PubMed, to step Checkpoint: 000937
- to stream Ncbi, to step Merge: 003099
- to stream Ncbi, to step Curation: 003099
- to stream Ncbi, to step Checkpoint: 003099
- to stream Main, to step Merge: 000B95
- to stream Main, to step Curation: 000B94
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.</title>
<author><name sortKey="Lin, Xianfeng" sort="Lin, Xianfeng" uniqKey="Lin X" first="Xianfeng" last="Lin">Xianfeng Lin</name>
</author>
<author><name sortKey="Shi, Houguang" sort="Shi, Houguang" uniqKey="Shi H" first="Houguang" last="Shi">Houguang Shi</name>
</author>
<author><name sortKey="Zhang, Weixing" sort="Zhang, Weixing" uniqKey="Zhang W" first="Weixing" last="Zhang">Weixing Zhang</name>
</author>
<author><name sortKey="Qiu, Zongxing" sort="Qiu, Zongxing" uniqKey="Qiu Z" first="Zongxing" last="Qiu">Zongxing Qiu</name>
</author>
<author><name sortKey="Zhou, Zheng" sort="Zhou, Zheng" uniqKey="Zhou Z" first="Zheng" last="Zhou">Zheng Zhou</name>
</author>
<author><name sortKey="Dey, Fabian" sort="Dey, Fabian" uniqKey="Dey F" first="Fabian" last="Dey">Fabian Dey</name>
</author>
<author><name sortKey="Zhong, Sheng" sort="Zhong, Sheng" uniqKey="Zhong S" first="Sheng" last="Zhong">Sheng Zhong</name>
</author>
<author><name sortKey="Qiu, Hongxia" sort="Qiu, Hongxia" uniqKey="Qiu H" first="Hongxia" last="Qiu">Hongxia Qiu</name>
</author>
<author><name sortKey="Xie, Jianxun" sort="Xie, Jianxun" uniqKey="Xie J" first="Jianxun" last="Xie">Jianxun Xie</name>
</author>
<author><name sortKey="Zhou, Xue" sort="Zhou, Xue" uniqKey="Zhou X" first="Xue" last="Zhou">Xue Zhou</name>
</author>
<author><name sortKey="Yang, Guang" sort="Yang, Guang" uniqKey="Yang G" first="Guang" last="Yang">Guang Yang</name>
</author>
<author><name sortKey="Tang, Guozhi" sort="Tang, Guozhi" uniqKey="Tang G" first="Guozhi" last="Tang">Guozhi Tang</name>
</author>
<author><name sortKey="Shen, Hong C" sort="Shen, Hong C" uniqKey="Shen H" first="Hong C" last="Shen">Hong C. Shen</name>
</author>
<author><name sortKey="Zhu, Wei" sort="Zhu, Wei" uniqKey="Zhu W" first="Wei" last="Zhu">Wei Zhu</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31689116</idno>
<idno type="pmid">31689116</idno>
<idno type="doi">10.1021/acs.jmedchem.9b01421</idno>
<idno type="wicri:Area/PubMed/Corpus">000862</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000862</idno>
<idno type="wicri:Area/PubMed/Curation">000862</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000862</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000937</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000937</idno>
<idno type="wicri:Area/Ncbi/Merge">003099</idno>
<idno type="wicri:Area/Ncbi/Curation">003099</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003099</idno>
<idno type="wicri:Area/Main/Merge">000B95</idno>
<idno type="wicri:Area/Main/Curation">000B94</idno>
<idno type="wicri:Area/Main/Exploration">000B94</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.</title>
<author><name sortKey="Lin, Xianfeng" sort="Lin, Xianfeng" uniqKey="Lin X" first="Xianfeng" last="Lin">Xianfeng Lin</name>
</author>
<author><name sortKey="Shi, Houguang" sort="Shi, Houguang" uniqKey="Shi H" first="Houguang" last="Shi">Houguang Shi</name>
</author>
<author><name sortKey="Zhang, Weixing" sort="Zhang, Weixing" uniqKey="Zhang W" first="Weixing" last="Zhang">Weixing Zhang</name>
</author>
<author><name sortKey="Qiu, Zongxing" sort="Qiu, Zongxing" uniqKey="Qiu Z" first="Zongxing" last="Qiu">Zongxing Qiu</name>
</author>
<author><name sortKey="Zhou, Zheng" sort="Zhou, Zheng" uniqKey="Zhou Z" first="Zheng" last="Zhou">Zheng Zhou</name>
</author>
<author><name sortKey="Dey, Fabian" sort="Dey, Fabian" uniqKey="Dey F" first="Fabian" last="Dey">Fabian Dey</name>
</author>
<author><name sortKey="Zhong, Sheng" sort="Zhong, Sheng" uniqKey="Zhong S" first="Sheng" last="Zhong">Sheng Zhong</name>
</author>
<author><name sortKey="Qiu, Hongxia" sort="Qiu, Hongxia" uniqKey="Qiu H" first="Hongxia" last="Qiu">Hongxia Qiu</name>
</author>
<author><name sortKey="Xie, Jianxun" sort="Xie, Jianxun" uniqKey="Xie J" first="Jianxun" last="Xie">Jianxun Xie</name>
</author>
<author><name sortKey="Zhou, Xue" sort="Zhou, Xue" uniqKey="Zhou X" first="Xue" last="Zhou">Xue Zhou</name>
</author>
<author><name sortKey="Yang, Guang" sort="Yang, Guang" uniqKey="Yang G" first="Guang" last="Yang">Guang Yang</name>
</author>
<author><name sortKey="Tang, Guozhi" sort="Tang, Guozhi" uniqKey="Tang G" first="Guozhi" last="Tang">Guozhi Tang</name>
</author>
<author><name sortKey="Shen, Hong C" sort="Shen, Hong C" uniqKey="Shen H" first="Hong C" last="Shen">Hong C. Shen</name>
</author>
<author><name sortKey="Zhu, Wei" sort="Zhu, Wei" uniqKey="Zhu W" first="Wei" last="Zhu">Wei Zhu</name>
</author>
</analytic>
<series><title level="j">Journal of medicinal chemistry</title>
<idno type="eISSN">1520-4804</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Described herein is a new approach to mitigate CYP3A4 induction. In this unconventional approach, a fine-tuning of the dihedral angle between the C4 phenyl and the dihydropyrimidine core of the heteroaryldihydropyrimidine (HAP) class of capsid inhibitors successfully altered the structure-activity-relationships (SARs) of the unwanted CYP3A4 induction and the desired HBV capsid inhibition to more favorable values. This eventually led to the discovery of a new capsid inhibitor with significantly reduced CYP3A4 induction, excellent anti-HBV activity, favorable preclinical PK/PD profiles, and no early safety flags.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Dey, Fabian" sort="Dey, Fabian" uniqKey="Dey F" first="Fabian" last="Dey">Fabian Dey</name>
<name sortKey="Lin, Xianfeng" sort="Lin, Xianfeng" uniqKey="Lin X" first="Xianfeng" last="Lin">Xianfeng Lin</name>
<name sortKey="Qiu, Hongxia" sort="Qiu, Hongxia" uniqKey="Qiu H" first="Hongxia" last="Qiu">Hongxia Qiu</name>
<name sortKey="Qiu, Zongxing" sort="Qiu, Zongxing" uniqKey="Qiu Z" first="Zongxing" last="Qiu">Zongxing Qiu</name>
<name sortKey="Shen, Hong C" sort="Shen, Hong C" uniqKey="Shen H" first="Hong C" last="Shen">Hong C. Shen</name>
<name sortKey="Shi, Houguang" sort="Shi, Houguang" uniqKey="Shi H" first="Houguang" last="Shi">Houguang Shi</name>
<name sortKey="Tang, Guozhi" sort="Tang, Guozhi" uniqKey="Tang G" first="Guozhi" last="Tang">Guozhi Tang</name>
<name sortKey="Xie, Jianxun" sort="Xie, Jianxun" uniqKey="Xie J" first="Jianxun" last="Xie">Jianxun Xie</name>
<name sortKey="Yang, Guang" sort="Yang, Guang" uniqKey="Yang G" first="Guang" last="Yang">Guang Yang</name>
<name sortKey="Zhang, Weixing" sort="Zhang, Weixing" uniqKey="Zhang W" first="Weixing" last="Zhang">Weixing Zhang</name>
<name sortKey="Zhong, Sheng" sort="Zhong, Sheng" uniqKey="Zhong S" first="Sheng" last="Zhong">Sheng Zhong</name>
<name sortKey="Zhou, Xue" sort="Zhou, Xue" uniqKey="Zhou X" first="Xue" last="Zhou">Xue Zhou</name>
<name sortKey="Zhou, Zheng" sort="Zhou, Zheng" uniqKey="Zhou Z" first="Zheng" last="Zhou">Zheng Zhou</name>
<name sortKey="Zhu, Wei" sort="Zhu, Wei" uniqKey="Zhu W" first="Wei" last="Zhu">Wei Zhu</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:31689116 |texte= A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:31689116" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |